SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

SGS742

Trial Locations (59)

10021

New York

13790

United Health Services Office of Clinical Trials, Johnson City

19004

Bala-Cynwyd

19046

The Clinical Trial Center, LLC, Jenkintown

23294

National Clinical Research, Inc., Richmond

27103

Winston-Salem

27607

Raleigh Neurology, Raleigh

27609

Raleigh

30030

CSI Research, Decatur

30033

DeKalb Neurology Associates, LLC, Decatur

32763

Orange City

33016

Berma Research Group, Hialeah

33064

Pompano Beach

33125

Allied Clinical Trials, The Neurology Group, Miami

33154

Baumel-Eisner Neuromedical Institute, Miami Beach

33161

Tukoi Institute for Clinical Research, Miami

33321

Baumel-Eisner Neuromedical Institute, Fort Lauderdale

33445

Brain Matters, Inc., Delray Beach

33461

Palm Springs

33486

Baumel-Eisner Neuromedical Institute, Inc., Boca Raton

33613

Tampa

33647

Tampa

34205

Bradenton Neurology, Inc., Bradenton

34471

Ocala Neurodiagnostic Center, Ocala

37115

Madison

43623

Toledo

44109

MetroHealth Medical Center, Cleveland

44120

University Memory and Aging Center, Cleveland

66214

MidAmerica Neuroscience Institute, Lenexa

71103

Neurology Department, LSU Health Sciences Center, Shreveport

72205

Clinical Trials Incorporated, Little Rock

73112

Lynn Health Science Institute, Oklahoma City

76309

Grayline Clinical Drug Trials, Wichita Falls

77401

Claghorn-Lesem Research Clinic, Ltd., Bellaire

78229

Radiant Research San Antonio, San Antonio

78238

Texas Medical Research Associates, LLC, San Antonio

78757

Senior Adults Specialty Research, Inc., Austin

80218

The Mile High Research Center, Denver

85013

Phoenix

85351

Dedicated Clinical Research, Sun City

85741

Northwest NeuroSpecialists, PLLC, Tucson

89102

SW Medical Associates, Las Vegas

91105

Neuro Therapeutics, Inc., Pasadena

91108

Southern California Clinical Research, Inc., San Marino

92037

Center for Neurologic Studies, La Jolla

92103

Pacific Research Network, Inc., San Diego

92108

Affiliated Research Institute, San Diego

92618

NervePro Research, Irvine

93720

Margolin Brain Institute, Fresno

94109

San Francisco Clinical Research Center, San Francisco

97401

Oregon Center for Clinical Investigations, Inc., Eugene

97504

Medford

06820

Research Center for Clinical Studies, Inc., Darien

06902

Stamford

01199

Baystate Medical Center, Springfield

08759

Paterson

08540

Psychopharmacology Research Association of Princeton, P.C., Princeton

02914

RI Mood & Memory Research Institute, East Providence

05201

Bennington

All Listed Sponsors
lead

Saegis Pharmaceuticals

INDUSTRY

NCT00093951 - SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) | Biotech Hunter | Biotech Hunter